Stéphane Bancel, Moderna CEO (Andrew Harnik/AP Images)
Truce: Moderna backs down in patent fight with NIH as it touts early booster data against Omicron
Moderna has backed down on its patent fight with the NIH, calling a truce by dropping its patent application for now.
Following a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
